Ondansetron Administration to Children With Gastroenteritis, Vomiting and SOME Dehydration in Emergency Departments in Pakistan

Trial Profile

Ondansetron Administration to Children With Gastroenteritis, Vomiting and SOME Dehydration in Emergency Departments in Pakistan

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Jan 2017

At a glance

  • Drugs Ondansetron (Primary)
  • Indications Dehydration; Vomiting
  • Focus Therapeutic Use
  • Acronyms OSEP
  • Most Recent Events

    • 06 Jan 2017 Planned End Date changed from 1 Oct 2018 to 1 Feb 2018.
    • 06 Jan 2017 Planned primary completion date changed from 1 Aug 2018 to 1 Sep 2017.
    • 20 Apr 2016 Trial phase changed from III to IV.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top